. "Rene Gonzalez" . . . . . "David Hogg" . . . "Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial"@en . "10.1016/S1470-2045(18)30700-9" . "Joel Jiang" . . . . "scientific article published on 22 October 2018"@en . . . . "Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial"@en . . . . . . . . "1480-1492" . . "Frank Stephen Hodi" . . . . . . . . "John Wagstaff" . "11" . . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u n'ochobre de 2018"@ast . . . . "Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial"@nl . . . . . . "Dirk Schadendorf" . . "Michael Smylie" . "Charles Lance Cowey" . . "Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial"@nl . . . . . . "Christopher D Lao" . . . . "wetenschappelijk artikel"@nl . "30361170" . . . "Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial"@nl . "2018-10-22T00:00:00Z"^^ . . . . . "Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial"@en . . . "im Oktober 2018 ver\u00F6ffentlicher wissenschaftlicher Artikel"@de . . "Andrew Hill" . . "James Larkin" . . . . . . "Jean-Jacques Grob" . "Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial"@en . . "19" . . . . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0436\u043E\u0432\u0442\u043D\u0456 2018"@uk . . "Jasmine Rizzo" . . .